clinical trial · NCT02517749
Out Patient Talc Slurry Via Indwelling Pleural Catheter for Malignant Pleural Effusion Vs Usual Inpatient Management
Pleural Effusion, MalignantChest Drain Insertion and Talc PleurodesisIndwelling Pleural Catheter Insertion and Talc Pleurodesis
brief summary
This is a multicentre randomised controlled trial evaluating global health related quality of life outcomes in patients with malignant pleural effusions. Patients will be randomised to receive either chest drain and talc pleurodesis or indwelling pleural catheter and talc pleurodesis. Patients will be followed up for 3 months post intervention
started
Aug 1, 2015
primary completion
Mar 1, 2020
completion
Mar 1, 2020
last updated
Nov 24, 2023
official title
Randomised Controlled Trial Comparing Outpatient Management of Malignant Pleural Effusion Via an Indwelling Pleural Catheter and Talc Pleurodesis Versus Standard Inpatient Management in Improving Health Related Quality of Life
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol